28 June 2018 - Deborah Wilkes
Archived
Stada Arzneimittel has acquired the rights to Johnson & Johnson's Nizoral (ketoconazole) anti-dandruff shampoo in Europe, the Middle East and Africa (EMEA) for an undisclosed sum.
New to OTCToolbox?
This is available as part of an Annual Subscription to the OTCToolbox website.